Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Genencor Int'l Inc. (NasdaqNM:GCOR)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials | Reports
Location
925 Page Mill Road
Palo Alto, CA 94304
Phone: (650) 846-7500
Fax: (650) 845-6500
Email: ir@genencor.com
Employees (last reported count): 1,077
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 87%
·Over the last 6 months:
 · 2 insider buys; 7,000  shares
·Institutional: 8% (65% of float)
(73 institutions)
·Net Inst. Buying: 463.0K shares (+8.38%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Genencor International, Inc. is a diversified biotechnology company that develops and delivers products and/or services to the industrial and consumer, agriculture and healthcare markets. The Company develops products that deliver solutions using an integrated set of technology platforms, including gene discovery and functional genomics, molecular evolution and design and human immunology. The Company markets and sells over 250 products that are distributed to over 500 customers in over 80 countries. The Company groups its marketed products into three general functional categories, consisting of enzymes that break down protein, starch or cellulose. These enzyme products are marketed for fabric care, including cleaning and textile processing, as well as the personal care market. In addition, the Company markets these classes of enzymes in the grain processing and specialties areas of the agriculture market.
More from Market Guide: Expanded Business Description

Financial Summary
Genencor Int'l, Inc. is engaged in the development of genetically based biotech. products, using technologies such as gene discovery and functional genomics, molecular evolution and design, and human immunology. For the six months ended 6/30/01, revenues fell less than 1% to $159.1 million. Net income applicable to Com. fell 62% to $6.7 million. Revenues reflect decreased fees and royalties. Earnings also suffered from increased investments in technology and product development.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

W. Thomas Mitchell, 55
Chairman, Pres, CEO
$754K$966K
Raymond Land, 56
Sr. VP, CFO
633K242K
Richard Ranieri, 49
Sr. VP of HR
590K242K
Michael Arbige, Ph.D., 46
Sr. VP, Technology
303K242K
Carole Cobb, 43
Sr. VP, Global Supply
--  --  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:GCORAs of 31-Aug-2001
Price and Volume
52-Week Low
on 4-Apr-2001
$6.75 
Recent Price$12.20 
52-Week High
on 5-Sep-2000
$36.625
Daily Volume (3-month avg)77.6K
Daily Volume (10-day avg)64.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y]
52-Week Change-59.0%
52-Week Change
relative to S&P500
-45.0%
Share-Related Items
Market Capitalization$731.0M
Shares Outstanding59.9M
Float7.80M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$4.07 
Earnings (ttm)$0.22 
Earnings (mrq)$0.04 
Sales (ttm)$5.17 
Cash (mrq)$3.35 
Valuation Ratios
Price/Book (mrq)3.00 
Price/Earnings (ttm)55.96 
Price/Sales (ttm)2.36 
Income Statements
Sales (ttm)$315.9M
EBITDA (ttm)$36.3M
Income available to common (ttm)$13.3M
Profitability
Profit Margin (ttm)6.5%
Operating Margin (ttm)8.4%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)3.42%
Return on Equity (ttm)6.11%
Financial Strength
Current Ratio (mrq)3.96 
Debt/Equity (mrq)0.37 
Total Cash (mrq)$201.0M
Short Interest
As of 8-Aug-2001
Shares Short39.0K
Percent of Float0.5%
Shares Short
(Prior Month)
86.0K
Short Ratio0.66 
Daily Volume59.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.